AIDS Drugs Can Save Heterosexuals from HIV
Two new research studies conducted in Africa reveal that antiretroviral drugs can protect heterosexuals from HIV infection. In one study, a pill named Truvada reduced HIV risk by 63%.
In the other study, a combination therapy of tenofovir (Viread) and Truvada was also found to reduce HIV transmission after heterosexual sex. The first study was conducted by the Botswana Ministry of Health in combination with U.S. Centers for Disease Control and Prevention (CDC).
Truvada also did not cause any strong side effects, but more people reported dizziness, vomiting and nausea after taking this retroviral drug, compared to those who took a placebo.
The second trial was conducted by the University of Washington which received funding from the Bill and Melinda Gates Foundation. It was conducted in Uganda and Kenya. This study found that the combination therapy of Viread and Truvada reduced HIV risk by 73% compared to the placebo. Truvada is already approved by the FDA to treat HIV in adults.